Clinical Trial Update: The Efficacy and Safety of Modified XELOX(mXELOX) Plus Cetuximab vs FOLFOX Plus Cetuximab in RAS and BRAF WT mCRC Pts [Phase 3]

View source ↗

Summary

Phase 3 trial comparing modified XELOX plus cetuximab versus FOLFOX plus cetuximab in RAS/BRAF wild-type metastatic colorectal cancer; at present status is unkn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Cetuximab (cetuximab)
• FOLFOX
• modified XELOX

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Colo-rectal Cancer | Phase 3 | Status: UNKNOWN